Fresenius Kabi

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Subsidiary

Established: 1999-01-01

Employees: -

Market Cap: -

Website: http://www.fresenius-kabi.com

Clinical Trials

Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section

Phase 4

Completed

Conditions: Hypotension

Interventions: Drug: HES 130/0.4 (6%) in sodium chloride (solution for infusion)
Drug: Ringer's Lactate solution

First Posted Date: 2008-06-10

Last Posted Date: 2012-05-31

Lead Sponsor: Fresenius Kabi

Target Recruit Count: 167

Registration Number: NCT00694343

Locations: 🇫🇷
CHU Hotel Dieu, Service Anesthesie, Lyon, France
🇫🇷
Höpital Louis-Mourier - Service d'Anesthesie, Colombes, France
🇫🇷
CHU Clermont Ferrand - Hotel Dieu, Service Anesthesie-Reanimation, Clermont Ferrand, France

and more 11 locations

Study on Safety, Tolerance and Metabolic Effects of a Nutritional Supplement, Given as a Drink Before Gallbladder Surgery

Not Applicable

Completed

Conditions: Enteral Nutrition Regimen Prior to Surgery

Interventions: Dietary Supplement: PreOP Booster (oral nutritional supplement, food for special medical purposes)

First Posted Date: 2008-04-21

Last Posted Date: 2008-12-08

Lead Sponsor: Fresenius Kabi

Target Recruit Count: 40

Registration Number: NCT00662376

Locations: 🇬🇧
Queen's Medical Centre, Division of Gastrointestinal Surgery, Nottingham University Hospitals;, Nottingham, United Kingdom

Gastric Emptying Study After Administration of a High Caloric Sip Feed

Not Applicable

Completed

Conditions: Enteral Nutrition

Interventions: Dietary Supplement: ProvideXtra DRINK (oral nutritional supplement, food for special medical purposes)

First Posted Date: 2008-01-25

Last Posted Date: 2008-05-15

Lead Sponsor: Fresenius Kabi

Target Recruit Count: 12

Registration Number: NCT00600678

Locations: 🇩🇪
SocraTec R&D GmbH, Clinical Pharmacology Unit, Erfurt, Thueringen, Germany

Preoperative Oral Nutritional Supplement (preOP Booster) in Visceral Surgery

Not Applicable

Completed

Conditions: Enteral Nutrition (Food for Special Medical Purposes)

Interventions: Dietary Supplement: preOP booster (oral nutritional supplement, food for special medical purposes)

First Posted Date: 2007-07-18

Last Posted Date: 2008-12-08

Lead Sponsor: Fresenius Kabi

Target Recruit Count: 36

Registration Number: NCT00503334

Locations: 🇮🇹
Università Salute-Vita San Raffaele,, Milan, Italy

Intradialytic Parenteral Nutrition in Hemodialysis Patients

Phase 4

Completed

Conditions: Malnutrition
Complication of Hemodialysis

Interventions: Drug: Intradialytic Parenteral Nutrition (IDPN)

First Posted Date: 2007-07-17

Last Posted Date: 2016-03-03

Lead Sponsor: Fresenius Kabi

Target Recruit Count: 140

Registration Number: NCT00501956

Locations: 🇩🇪
Interneph e.V. Institute for Applied Nephrology, Aachen, Germany

Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis

Phase 3

Completed

Conditions: Sepsis

Interventions: Drug: 6 % Hydroxyethylstarch 130/0.4 = "Voluven®"
Drug: 0.9 % NaCl

First Posted Date: 2007-04-23

Last Posted Date: 2012-01-11

Lead Sponsor: Fresenius Kabi

Target Recruit Count: 196

Registration Number: NCT00464204

Locations: 🇫🇷
CHU de Dijon - Hôpital du Bocage Service de Réanimation Médicale, Dijon, France
🇫🇷
Hôpital Lapeyronie / CHU Montpellier, Département d'Anesthésie Réanimation, Montpellier, France
🇫🇷
Hôpital Central, Service Anesthésie-Réanimation, Chirurgicale CHU, Nancy, France

and more 21 locations

Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition

Phase 3

Completed

Conditions: Parenteral Nutrition

Interventions: Drug: SMOF lipid and Intralipid

First Posted Date: 2007-03-23

Last Posted Date: 2010-08-27

Lead Sponsor: Fresenius Kabi

Target Recruit Count: 75

Registration Number: NCT00451646

Locations: 🇩🇰
Rigshospitalet, Department of Medical Gastroenterology, Copenhagen, Denmark
🇬🇧
University Hospital, Queen's Medical Centre, Nottingham, United Kingdom
🇦🇺
North Shore Private Hospital, Saint Leonards, New South Wales, Australia

and more 9 locations

Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)

Phase 4

Completed

Conditions: Diabetic Nephropathy

Interventions: Drug: Ketosteril®
Other: diabetic diet

First Posted Date: 2006-08-15

Last Posted Date: 2010-09-02

Lead Sponsor: Fresenius Kabi

Target Recruit Count: 179

Registration Number: NCT00363987

Locations: 🇨🇳
Shanghai Huashan Hospital, Shanghai, China

Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation

Phase 4

Terminated

Conditions: Intraoperative Complications

Interventions: Drug: Hydroxyethylstarch 130/0.4
Drug: 5% Albumin

First Posted Date: 2006-03-29

Last Posted Date: 2009-01-15

Lead Sponsor: Fresenius Kabi

Target Recruit Count: 53

Registration Number: NCT00308100

Locations: 🇨🇳
People's Hospital of Peking University, Beijing, China

Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery

Phase 4

Completed

Conditions: Postoperative Complications

First Posted Date: 2006-03-29

Last Posted Date: 2007-12-11

Lead Sponsor: Fresenius Kabi

Target Recruit Count: 624

Registration Number: NCT00308126

Locations: 🇨🇳
Peking Union Medical College (PUMC) Hospital, Beijing, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy